Janus Henderson Group
RVMD icon

Janus Henderson Group’s Revolution Medicines RVMD Stock Holding History

Janus Henderson Group’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$950M Sell
9,766,496
-2,537,006
-21% -$256M 0.45% 42
2025
Q4 		$980M Buy
12,303,502
+947,448
+8% +$62.1M 0.44% 42
2025
Q3 		$530M Buy
11,356,054
+765,327
+7% +$30M 0.24% 93
2025
Q2 		$390M Buy
10,590,727
+400,656
+4% +$15.4M 0.19% 118
2025
Q1 		$381M Buy
10,190,071
+706,072
+7% +$28.7M 0.21% 116
2024
Q4 		$415M Buy
9,483,999
+3,346,755
+55% +$169M 0.21% 110
2024
Q3 		$278M Buy
6,137,244
+1,497,026
+32% +$65.2M 0.14% 159
2024
Q2 		$180M Buy
4,640,218
+728,099
+19% +$27.2M 0.1% 184
2024
Q1 		$126M Buy
3,912,119
+1,712,639
+78% +$50.8M 0.07% 236
2023
Q4 		$63.1M Sell
2,199,480
-41,259
-2% -$991K 0.04% 332
2023
Q3 		$62M Buy
2,240,739
+922,897
+70% +$27.4M 0.04% 326
2023
Q2 		$35.2M Buy
1,317,842
+965,014
+274% +$23.7M 0.02% 461
2023
Q1 		$7.64M Buy
352,828
+343,212
+3,569% +$8.45M 0.01% 763
2022
Q4 		$229K Buy
+9,616
New +$204K ﹤0.01% 2118
2022
Q2 		– Sell
-9,668
Closed -$246K – 2670
2022
Q1 		$246K Buy
9,668
+2
+0% +$44 ﹤0.01% 2341
2021
Q4 		$243K Buy
+9,666
New +$272K ﹤0.01% 2299

Other funds holding RVMD

FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Janus Henderson Group's RVMD Position: Q1 2026 in Review

Janus Henderson Group reduced its Revolution Medicines (RVMD) stake by 21% in Q1 2026, selling an estimated $256M and leaving 9,766,496 shares worth $950M. The position accounts for 0.45% of the portfolio, ranked #42.

Janus Henderson Group first reported a position in RVMD in Q4 2021 and has held it in 16 quarters since. The position peaked at $980M in Q4 2025. 514 funds tracked by Wall St. Rank hold RVMD as of Q1 2026.

  • Janus Henderson Group held 9,766,496 shares of Revolution Medicines worth $950M as of Q1 2026.
  • Janus Henderson Group sold 2,537,006 Revolution Medicines shares in Q1 2026, an estimated $256M.
  • Revolution Medicines made up 0.45% of Janus Henderson Group's portfolio in Q1 2026, its #42 holding.
  • Janus Henderson Group first reported a position in Revolution Medicines in Q4 2021 and has held it in 16 quarters since.
  • Janus Henderson Group's Revolution Medicines position peaked at $980M in Q4 2025.
  • 514 funds tracked by Wall St. Rank held Revolution Medicines as of Q1 2026.

Based on Janus Henderson Group's 13F filing for Q1 2026, filed 15 May 2026.